NEW
YORK, June 26, 2024 /PRNewswire/ -- The global
immunohematology market size is estimated to grow by USD 1.06 billion from 2024-2028, according to
Technavio. The market is estimated to grow at a CAGR of
7.35% during the forecast period. Shift by
end-users to automated immunohematology analyzers is driving market
growth, with a trend towards paradigm shift toward molecular
immunohematology. However, high maintenance cost and low
reimbursement for blood components poses a challenge. Key
market players include Becton
Dickinson and Co., Biomed Global, Bio Rad Laboratories Inc.,
biosurfit SA, Cardinal Health Inc., Calibre Scientific Inc.,
Danaher Corp., DIAGAST SAS, Grifols SA, Hemo bioscience Inc., HUMAN
Gesellschaft fur Biochemica und Diagnostica mbH, Institut de
Biotechnologies Jacques Boy, MAK SYSTEM S.A., Merck KGaA, Mesa
Laboratories Inc., Quotient Ltd., Siemens AG, Thermo Fisher
Scientific Inc., Tulip Diagnostics Pvt. Ltd., and Werfenlife
SA.
![Technavio has announced its latest market research report titled Global immunohematology market 2024-2028 Technavio has announced its latest market research report titled Global immunohematology market 2024-2028](https://mma.prnewswire.com/media/2447409/IRTNTR45886_bw2.jpg)
Get a detailed analysis on regions, market
segments, customer landscape, and companies - Click for the
snapshot of this report
Forecast
period
|
2024-2028
|
Base Year
|
2023
|
Historic
Data
|
2018 - 2022
|
Segment
Covered
|
Product (Analyzers and
systems and Reagents), End-user (Hospitals, Blood banks, and
Diagnostic laboratories), and Geography (North America, Europe,
Asia, and Rest of World (ROW))
|
Region
Covered
|
North America, Europe,
Asia, and Rest of World (ROW)
|
Key companies
profiled
|
Becton Dickinson and
Co., Biomed Global, Bio Rad Laboratories Inc., biosurfit SA,
Cardinal Health Inc., Calibre Scientific Inc., Danaher Corp.,
DIAGAST SAS, Grifols SA, Hemo bioscience Inc., HUMAN Gesellschaft
fur Biochemica und Diagnostica mbH, Institut de Biotechnologies
Jacques Boy, MAK SYSTEM S.A., Merck KGaA, Mesa Laboratories Inc.,
Quotient Ltd., Siemens AG, Thermo Fisher Scientific Inc., Tulip
Diagnostics Pvt. Ltd., and Werfenlife SA
|
Key Market Trends Fueling Growth
Molecular analysis plays a crucial role in the detection of
antigen molecular and genetic structures, enhancing clinicians'
understanding of blood group antigens and blood typing. This method
is now a standard practice before unrelated donor blood
transfusions due to cross-matching requirements. The adoption of
molecular immunohematology, alongside serological and HLA typing,
is on the rise in blood banks and hospitals. This shift towards
advanced molecular techniques is expected to fuel the growth of the
global immunohematology market.
The Immunohematology market is experiencing significant growth
due to the increasing demand for advanced diagnostic tools and
technologies. Blood products and associated technologies are key
areas of focus. For instance, forms of assays such as ELISA,
Western blot, and flow cytometry are commonly used in
immunohematology. These techniques aid in the detection and
identification of various antigens and antibodies. Additionally,
the use of automated systems and digital technologies is on the
rise, streamlining processes and improving accuracy. The market is
also driven by the need for personalized medicine and the
development of new therapeutic approaches. Overall, the
immunohematology market is expected to continue its upward trend in
the coming years.
Research report provides comprehensive data on
impact of trend. For more details- Download a Sample
Report
Market Challenges
- Blood component maintenance costs, including labor, reagents,
and disposables, as well as storage, are escalating, burdening
blood banks. Cord blood handling costs approximately USD1,500 yearly. Despite the higher probability
of releasing erythrocytes and plasma to end-users, their adoption
is low due to insufficient reimbursements. The RBC unit costs
around USD150-USD165, but reimbursement is only USD75-USD80. High
maintenance costs and low reimbursements can hinder blood component
adoption, negatively impacting the immunohematology market's
growth.
- The Immunohematology market faces several challenges in
providing effective diagnostic solutions. Blood and antigens, such
as maligances and antidotes, play a crucial role in this field.
However, creating and distributing these products requires careful
consideration. Devices and processes, like centrifuges and
reagents, are necessary for testing and analysis. Yet, ensuring
their reliability and accuracy can be challenging. Additionally,
regulations and compliance, such as Hepatitis and FDA requirements,
add complexity to the industry. The need for precision and
efficiency in testing and delivery is essential to meet the demands
of healthcare providers and patients alike.
For more insights on driver and
challenges - Download a Sample Report
Segment Overview
This immunohematology market report extensively covers market
segmentation by
- Product
- 1.1 Analyzers and systems
- 1.2 Reagents
- End-user
- 2.1 Hospitals
- 2.2 Blood banks
- 2.3 Diagnostic laboratories
- Geography
- 3.1 North America
- 3.2 Europe
- 3.3 Asia
- 3.4 Rest of World (ROW)
1.1 Analyzers and systems- The global
immunohematology market is expected to grow significantly due to
the increasing demand for automated analyzers in blood banks and
next-generation immunohematology systems. Large blood banks, such
as the NHSBT in the UK, require efficient solutions to process the
high volume of blood donations and screenings. Automated analyzers,
like Immucor's NEO and Bio-Rad's IH-500, offer enhanced speed,
performance, and reliability, making them preferred choices for
Tier 1 hospitals and blood banks. These analyzers can process large
numbers of samples simultaneously and provide more accurate results
compared to manual methods. The market growth is further driven by
the potential for replacing conventional manual testing methods
with automated solutions.
For more information on market segmentation with
geographical analysis including forecast (2024-2028) and historic
data (2018 - 2022) - Download a Sample Report
Research Analysis
The Immunohematology market encompasses various services and
technologies related to the management of blood transfusion, blood
donation, and blood disorders. This includes the provision of
elective surgical procedures, immunohematology tests, and blood
products. Key areas of focus within this market are the prevention
and management of immunity-related reactions, transplant-related
reactions, and pregnancy-related reactions. Blood banks play a
crucial role in ensuring a steady supply of safe blood and blood
components for patients with conditions such as leukemia,
hemophilia, and sickle cell disease. The market also includes
advancements in immunohematology technologies to address blood
associated diseases, infections, and the storage of blood
components. Amidst the ongoing coronavirus pandemic, awareness
campaigns are essential to ensure the safety and efficacy of blood
transfusion services and the availability of essential blood
products.
Market Research Overview
The Immunohematology market encompasses diagnostic tests and
technologies used to study the interaction between the immune
system and blood. This field is crucial in identifying and managing
various blood disorders, transfusion medicine, and immunological
diseases. Technologies such as flow cytometry, agglutination
testing, and gel card testing are commonly used in
immunohematology. These techniques aid in the detection and
quantification of various blood components, including red and white
blood cells, platelets, and antibodies. Immunohematology plays a
vital role in ensuring the safety and efficacy of blood
transfusions, as well as in the diagnosis and monitoring of
hematological malignancies and other immune-mediated disorders.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
- Product
-
- Analyzers And Systems
- Reagents
- End-user
-
- Hospitals
- Blood Banks
- Diagnostic Laboratories
- Geography
-
- North America
- Europe
- Asia
- Rest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory
company. Their research and analysis focuses on emerging market
trends and provides actionable insights to help businesses identify
market opportunities and develop effective strategies to optimize
their market positions.
With over 500 specialized analysts, Technavio's report library
consists of more than 17,000 reports and counting, covering 800
technologies, spanning across 50 countries. Their client base
consists of enterprises of all sizes, including more than 100
Fortune 500 companies. This growing client base relies on
Technavio's comprehensive coverage, extensive research, and
actionable market insights to identify opportunities in existing
and potential markets and assess their competitive positions within
changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/immunohematology-market-size-is-set-to-grow-by-usd-1-06-billion-from-2024-2028--shift-by-end-users-to-automated-immunohematology-analyzers-to-boost-the-market-growth-technavio-302182784.html
SOURCE Technavio